This antibiotic is effective against anthrax and has no detectable resistance

The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in collaboration with university startup NovoBiotic—has already proven itself against MRSA and pneumonia.